Skip to main navigation Skip to search Skip to main content

Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs

  • R. van der Lee
  • , M. Pfaffendorf
  • , P. A. van Zwieten

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The biphasic contractile responses of rat isolated mesenteric, renal, coronary and basilar small arteries to potassium-induced depolarization were investigated. The tonic phase is assumed to be exclusively the result of L-type calcium channel (LCC) activation, whereas in the generation of the phasic phase T-type calcium channels (TCC) may be involved. In order to evaluate whether TCC blockade has any influence on depolarization-induced contractions the effects of the LCC antagonists nifedipine, diltiazem and verapamil were compared with those of the combined L- and TCC antagonist mibefradil. Small arteries (size 393.6 +/- 4.8 microns, n = 104) were dissected from the respective organs of male Wistar rats (300-350 g) and studied in an isometric wire myograph. The effects of increasing concentrations of the calcium antagonists on repetitive potassium-induced contractions were quantified by means of cumulative concentration-response curves. A comparison was made with mesenteric vessels of SHR and WKY for nifedipine and mibefradil. Nifedipine was the most potent compound in blocking both the phasic phase (reduction 66-77%) and the tonic phase (IC50 = 1.1-5.4 nM). The effect of mibefradil on the phasic response was comparable to that of verapamil and diltiazem. With respect to the tonic response mibefradil was comparable to verapamil (IC50 = 19.6-178.9 nM). These findings indicate that the TCC blockade does not contribute to the vasodilator effect of mibefradil under the conditions investigated
Original languageEnglish
Pages (from-to)198-203
JournalFundamental & clinical pharmacology
Volume13
Issue number2
Publication statusPublished - 1999

Fingerprint

Dive into the research topics of 'Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs'. Together they form a unique fingerprint.

Cite this